Results 201 to 210 of about 249,684 (338)

Peptide‐Based Biomaterials as a Promising Tool for Cancer Radiotherapy

open access: yesAdvanced Science, EarlyView.
This review provides a systematic overview of peptide‐based biomaterials in tumor radiotherapy, covering their roles as both radiosensitizers and radiopharmaceuticals. Peptide‐based radiosensitizers are generally divided into three categories: peptides as direct radiosensitizers, peptides as carriers of radiosensitizers, and targeted‐peptide‐modified ...
Qian Wang, Xinhui Chu, Jianfeng Liu
wiley   +1 more source

Leptin Aggravates Thoracic Aortic Dissection Through Impairment of Energy Metabolism in Nrip2+ Smooth Muscle Cells

open access: yesAdvanced Science, EarlyView.
Epidemiological data confirm obesity elevates thoracic aortic dissection (TAD) risk. Patient analyses implicate hyperleptinemia, where leptin binding to vascular smooth muscle cell (VSMC) receptors triggers Socs3‐mediated suppression of Stat5a transcriptional activity.
Ling Chen   +18 more
wiley   +1 more source

Proton Therapy in Uveal Melanoma. [PDF]

open access: yesCancers (Basel)
Chan AW   +5 more
europepmc   +1 more source

UV‐Triggered Cascading Degradation of Silicone Elastomer via Self‐Fluoride Amplification

open access: yesAdvanced Science, EarlyView.
UV‐triggered degradable materials offer proficient control of functional lifetime, while having issues with trigger efficiency. This work enhances the UV‐triggered degradation mechanism of silicone elastomer by introducing the UV‐initiated synergetic fluoride self‐amplification. The silicone composite shows excellent mechanical properties and on‐demand
Yoon‐Nam Kim   +5 more
wiley   +1 more source

Instantaneous in vivo distal edge verification in intensity-modulated proton therapy by means of PET imaging. [PDF]

open access: yesMed Phys
Zapien-Campos B   +5 more
europepmc   +1 more source

Proton therapy of cancer: Potential clinical advantages and cost-effectiveness [PDF]

open access: bronze, 2005
Jonas Lundkvist   +4 more
openalex   +1 more source

Targeted Dual‐Responsive Liposomes Co‐Deliver Jolkinolide B and Ce6 to Synergistically Enhance the Photodynamic/Immunotherapy Efficacy in Gastric Cancer through the PANoptosis Pathway

open access: yesAdvanced Science, EarlyView.
Schematic model of CJP–TiN liposomes for gastric cancer (GC) treatment. Internalizing RGD peptide (iRGD) targets tumor cells, while Chlorin e6 (Ce6) generates reactive oxygen species (ROS). Jolkinolide B (JB) activates the PANoptosis pathway via caspase‐8, enhancing GC cell death and immune response, transforming “cold tumors” into “hot tumors” by ...
Chenhui Ma   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy